Ortho Clinical Diagnostics Holdings plc (OCDX) Social Stream
Ortho Clinical Diagnostics Holdings plc (OCDX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Ortho Clinical Diagnostics Holdings plc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
OCDX's average price target has moved down $3.06 over the prior 56 days.
OCDX reports an average of 39.19% for its upside potential over the past 31 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
OCDX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
OCDX's average broker recommendation rating worsened by 0.29 over the prior 62 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for OCDX as an investment opportunity.
- OCDX has a higher average analyst price target than 203.63% of all US stocks.
- In terms of how Ortho Clinical Diagnostics Holdings plc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 108.26% of that group.
- OCDX has a lower variance in analysts' estimates than -78.85% of Pharmaceutical Products stocks.
- In terms of how Ortho Clinical Diagnostics Holdings plc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 406.2% of that group.
In the Pharmaceutical Products industry, NEOG, MYGN, and LNTH are the three stocks most similar to Ortho Clinical Diagnostics Holdings plc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding OCDX using the data that counts. Try POWR Ratings for free.